Global clinical symptom spectrum in gastroesophageal reflux disease

Journal of Clinical Gastroenterology

Volumn 41, Issue SUPPL.2, 2007, Pages

  Mönnikes, Hubert ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Diagnosis; Extraesophageal symptoms; GERD; ReQuest

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ASTHMA; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REFLUX ESOPHAGITIS; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; THORAX PAIN;

EID: 34250762702     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318033dfa2     Document Type: Conference Paper

References (38)

1. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut. 1999;44(suppl 2):S1-S16.
2. Vakil N, van Zanten SV, Kahrilas P, et al. Gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-1920.
3. Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastro-esophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112: 1448-1456.
4. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275-285.
5. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205-208.
6. Moayyedi P, Axon ATR. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol. 1999;94: 3122-3125.
7. Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518-527.
8. Schindlbeck NE, Klauser AG, Voderholzer WA, et al. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med. 1995;155:1808-1812.
9. Bochenek WJ, Mack ME, Fraga PD, et al. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis. Aliment Pharmacol Ther. 2004;20:1105-1114.
10. Richter JE. Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;22(suppl 1):70-80.
11. Mönnikes H, Bardhan KD, Stanghellini V, et al. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERD. Digestion. 2004;69:238-244.
12. Bardhan KD, Stanghellini V, Armstrong D, et al. International validation of ReQuest™ in patients with endoscopy-negative gastrooesophageal reflux disease. Aliment Pharmacol Ther. 2004;20: 891-898.
13. Mönnikes H. The complete remission concept. Drugs Today. 2006;42(suppl B):9-14.
14. Stanghellini V, Cogliandro R, Cogliandro L, et al. Unsolved problems in the management of patients with gastro-oesophageal reflux disease. Dig Liver Dis. 2003;35:843-848.
15. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998;10:119-124.
16. Fass R, Stanghellini V, Mönnikes H, et al. Baseline analysis of symptom spectrum in GERD clinical trials: results from the ReQuest™ database. Gastroenterology. 2006;130(suppl 2):A-629.
17. Bardhan KD, Berghöfer P. Look - But also listen! ReQuest™: an essay on a new validated scale to assess the outcome of GERD treatment. Digestion. 2007;75(suppl 1):87-100.
18. Smout A. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther. 1997;11(suppl 2):81-85.
19. Gatz G, Braun W. New insights into GERD symptomatology: the ReQuest™ database. Gut. 2005;54(suppl VII):A112.
20. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172-180.
21. Richter JE. Extraoesophageal presentations of gastroesophageal reflux disease: an overview. Am J Gastroenterol. 2000;95(suppl): S1-S3.
22. Cherian P, Smith LF, Bardhan KD. Esophageal tests in the evaluation of non cardiac chest pain. Dis Esophagus. 1995;8:129-133.
23. Cremonini F, Wise J, Moayyedi P, et al. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterology. 2005;100: 1226-1232.
24. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115:42-49.
25. Wang WH, Huang JQ, Zheng GF, et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? Arch Intern Med. 2005;165:1222-1228.
26. Harding SM. Recent clinical investigations examining the association of asthma and gastroesophageal reflux. Am J Med. 2003;115: S39-S44.
27. Harding SM, Sontag SJ. Asthma and gastroesophageal reflux. Am J Gastroenterol. 2000;95(suppl):523-532.
28. Sontag SJ, Schnell TG, Miller TQ, et al. Prevalence of oesophagitis in asthmatics. Gut. 1992;33:872-876.
29. Harding DM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. 2000;162:34-39.
30. Brightling CE, Ward R, Goh KL, et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med. 1999;160:406-410.
31. Mello CJ, Irwin RS, Curley FJ. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med. 1996;156:997-1003.
32. Irwin RS, Richter JE. Gastroesophageal reflux and chronic cough. Am J Gastroenterol. 2000;95(suppl):S8-S14.
33. Irwin RS, French CL, Curley FJ, et al. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic and pathogenic aspects. Chest. 1993;104:1511-1517.
34. Kiljander TO, Salomas ERM, Hietanen EK, et al. Chronic cough and gastro-oesophageal reflux: a double-blind placebo controlled study with omeprazole. Eur Respir J. 2000;16: 633-638.
35. Shaker R, Castell DO, Schoenfeld PS, et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup Survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487-1493.
36. Richter JE, Bochenek W, the Pantoprazole US GERD Study Group. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Am J Gastroenterol. 2000;95: 3071-3080.
37. Johnson DA, Orr WC, Crawley JA, et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol. 2005;100: 1914-1922.
38. Cohen JA, Arain A, Harris PA, et al. Surgical trial investigating nocturnal gastroesophageal reflux and sleep (STINGERS). Surg Endosc. 2003;17:394-400.